pCLXSN-c-JUN Citations (3)
Originally described in: JNK signaling mediates EPHA2-dependent tumor cell proliferation, motility, and cancer stem cell-like properties in non-small cell lung cancer.Song W, Ma Y, Wang J, Brantley-Sieders D, Chen J Cancer Res. 2014 May 1;74(9):2444-54. doi: 10.1158/0008-5472.CAN-13-2136. Epub 2014 Mar 7. PubMed Journal
Articles Citing pCLXSN-c-JUN
| Articles |
|---|
| The CDK4/6-EZH2 pathway is a potential therapeutic target for psoriasis. Muller A, Dickmanns A, Resch C, Schakel K, Hailfinger S, Dobbelstein M, Schulze-Osthoff K, Kramer D. J Clin Invest. 2020 Jul 23. pii: 134217. doi: 10.1172/JCI134217. PubMed |
| Targeting KDM4A epigenetically activates tumor-cell-intrinsic immunity by inducing DNA replication stress. Zhang W, Liu W, Jia L, Chen D, Chang I, Lake M, Bentolila LA, Wang CY. Mol Cell. 2021 May 20;81(10):2148-2165.e9. doi: 10.1016/j.molcel.2021.02.038. Epub 2021 Mar 19. PubMed |
Conversion of natural cytokine receptors into orthogonal synthetic biosensors.
Edelstein HI, Cosio A, Ezekiel ML, Corcoran WK, Morris AH, Leonard JN.
Nat Chem Biol. 2025 Aug 22:10.1038/s41589-025-01986-1. doi: 10.1038/s41589-025-01986-1.
PubMed
Associated Plasmids
|
If you have published an article using this material, please email us at [email protected] to have your article added to this page.